Location History:
- San Luis Obispo, CA (US) (1995 - 1998)
- Florham Park, NJ (US) (2006)
- Berkeley Heights, NJ (US) (2010)
- Rancho Santa Fe, CA (US) (1998 - 2011)
Company Filing History:
Years Active: 1995-2011
Title: Innovations and Contributions of Robert E Klem
Introduction
Robert E Klem is a notable inventor based in Rancho Santa Fe, California. He has made significant contributions to the field of medical therapeutics, holding a total of eight patents. His work primarily focuses on the modulation of nucleic acid-based therapies and the treatment of various disorders.
Latest Patents
Among his latest patents, Klem has developed methods for modulating the efficacy of nucleic acid-based therapies. This includes covalently reactive antigen analogs that can stimulate the production of catalytic antibodies specific to predetermined antigens associated with particular medical disorders. These antigen analogs are also designed to permanently inactivate endogenously produced catalytic antibodies in certain autoimmune diseases and lymphoproliferative disorders. Additionally, he has patented methods for treating bcl-2 related disorders using bcl-2 antisense oligomers. This invention aims to treat and prevent disorders such as cancers and tumors by administering bcl-2 antisense oligomers at high doses.
Career Highlights
Throughout his career, Robert E Klem has worked with various companies, including Genta Incorporated and Jbl Scientific, Inc. His innovative approaches have led to advancements in therapeutic methods that address critical health issues.
Collaborations
Klem has collaborated with notable individuals in his field, including Timothy Andrew Riley and William Marvin. These partnerships have contributed to the development of his groundbreaking inventions.
Conclusion
Robert E Klem's contributions to medical therapeutics through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of innovative treatments for various medical disorders.